Results 31 to 40 of about 2,215 (200)

Evaluation of Follow-Up and Treatment Results in Coats’ Disease

open access: yes, 2016
Objectives: The aim of this study was to evaluate the clinical features, follow-up and treatment results of patients diagnosed with Coats’ disease. Materials and Methods: Medical records of 27 patients diagnosed with Coats’ disease in our clinic were ...
Bayraktar, Serife   +9 more
core   +1 more source

Coats disease in female population: A comparison of clinical presentation and outcomes

open access: yesFrontiers in Medicine, 2022
PurposeTo compare clinical characteristics at presentation and outcomes of Coats disease between females and males.MethodsIn this retrospective, consecutive case series we included all children diagnosed with Coats disease in a single tertiary referral ...
Gwendoline Piquin   +7 more
doaj   +1 more source

Fovea-sparing coats disease: A rare clinical entity

open access: yes, 2021
Purpose: To evaluate the rarity, clinical features and management of Coats disease characterized by fovea-sparing enhancing the importance of pediatric retinal screening and early management to maintain a good visual acuity.
Hadjistilianou T.   +5 more
core   +1 more source

Coats plus syndrome with new observation of drusenoid retinal pigment epithelial detachments in a teenager

open access: yesAmerican Journal of Ophthalmology Case Reports, 2022
Purpose: To describe a case of Coats Plus Syndrome (CPS), a vision and life threatening disease belonging to a family of diseases known as the Telomere Biology Disorders. Observations: A 15-year-old girl with a history of small for gestational age, short
Kushal U. Agrawal   +2 more
doaj   +1 more source

Claudin‐6 Protein Expression in Atypical Teratoid/Rhabdoid Tumors Is Strongly Enriched in the Molecular Subgroup AT/RT‐TYR

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Claudin‐6 has emerged as a promising immunotherapeutic target, yet protein‐level data in atypical teratoid/rhabdoid tumors (AT/RTs) have been inconsistent. We analyzed 36 well‐characterized AT/RT samples and found membranous claudin‐6 protein expression in 58% of cases, with striking enrichment in the molecular subgroup AT/RT‐TYR (100%) and ...
Victoria E. Fincke   +4 more
wiley   +1 more source

Long-term follow-up of a case of Coats disease in a 10-year-old boy with spontaneous peeling of preretinal macular fibrosis: a case report

open access: yesBMC Ophthalmology, 2022
Background Coats disease is a retinal vascular disorder characterized by aneurysms and telangiectasias. Macular fibrosis is a complication of Coats disease that results in vision loss.
Tomoka Mizobuchi   +3 more
doaj   +1 more source

Experience with Intravitreal Ranibizumab as an Adjunct to Ablation Therapy in Eyes with Exudative Coats’ Disease

open access: yesClinical Ophthalmology, 2021
Mohamed Nowara,1,2 Yousef A Fouad,1,3 Ihab Abdel Aziz,1,4 Ahmed M Habib,1,3 Mariam Al-feky,1,3 Hisham Hassan1 1Al Mashreq Eye Center, Cairo, Egypt; 2Department of Ophthalmology, Electricity Hospital, Cairo, Egypt; 3Department of Ophthalmology, Ain Shams ...
Nowara M   +5 more
doaj  

Vitrectomy for full-thickness macular hole in adult-onset Coats' disease

open access: yesIndian Journal of Ophthalmology, 2017
The occurrence of full thickness macular hole in Coats' disease is extremely rare. The purpose of this case report is to report pars plana vitrectomy for the treatment of full thickness macular hole in a patient with adult onset Coats disease.
Vinod Kumar   +3 more
doaj   +1 more source

Effects of the Fluid Replacement Method During Online Hemodiafiltration on the Solute Removal Performance and Biocompatibility Using the Asymmetric Cellulose Triacetate Membrane

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Introduction Pre‐dilution online hemodiafiltration (Pre‐HDF) is predominantly used in Japan, whereas post‐dilution online HDF (Post‐HDF) is more common in Europe. An asymmetric cellulose triacetate (ATA) membrane may improve biocompatibility.
Kenji Sakurai   +4 more
wiley   +1 more source

Summary of the human AH samples from the patients with Coats' disease and the controls without Coats' disease.

open access: yes, 2016
Summary of the human AH samples from the patients with Coats' disease and the controls without Coats' disease.
Wenbin Wei (150871)   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy